Blockchain Registration Transaction Record
Oragenics Advances Breakthrough Concussion Treatment with Intranasal Delivery Tech
Oragenics (OGEN) is revolutionizing concussion treatment with its intranasal delivery tech, aiming for FDA approval. Discover how this could change neurological care.

This news is pivotal as it highlights a potential breakthrough in treating concussions and other neurological conditions, offering hope for millions affected worldwide. Oragenics' innovative approach could significantly reduce recovery times and improve outcomes, marking a major advancement in neurological care. The implications extend beyond concussions, with potential applications in treating a range of brain-related conditions, underscoring the transformative potential of this technology in healthcare.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xe5182368eb86b6d9a874c152a01a0c1f2b26e7658b403cc8dda1ad24a6279892 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | bendOlUQ-c0908619e5a21cb494181097d98c0477 |